<DOC>
	<DOCNO>NCT00953472</DOCNO>
	<brief_summary>The investigator work hypothesis human hypertension part due derangement endocrine function heart - primary secondary mechanism - result relative deficiency natriuretic peptide ( NP ) . The remodeled hypertensive heart could result altered processing degradation B-type NP result alter molecular form decrease biological activity . The investigator hypothesize chronic administration BNP subject hypertension , feasible , safe induce sustain reduction blood pressure .</brief_summary>
	<brief_title>B-type Natriuretic Peptide ( BNP ) Human Hypertension</brief_title>
	<detailed_description>Ongoing investigation laboratory group others establish heart endocrine organ well pump . The heart synthesize secretes two peptide hormone - atrial natriuretic peptide ( ANP ) B-type natriuretic peptide ( BNP ) - endogenous ligand particulate guanylyl cyclase receptor ( NPR-A ) . Following receptor bind generation second messenger cGMP , natriuretic peptide ( NPs ) mediate biological action include natriuresis , inhibition renin-angiotensin system vasodilatation local autocrine paracrine action heart include inhibition fibrosis enhancement diastolic function . Hypertension remain global burden cardiovascular disease lead stroke , myocardial infarction heart failure . Its myocardial complication result increased mechanical load heart . Under physiological condition increase myocardial load result myocardial stretch , ANP BNP synthesis secretion occur contribute maintenance optimal cardiorenal blood pressure homeostasis .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Age &gt; 18 year . Subjects stage 1 hypertension ( SBP : 140159 mm Hg DBP 9099 mm Hg ) If therapy , must stable least 1 month . Congestive Heart Failure ( NYHA class ) . EF &lt; 50 % . Myocardial infarction within 3 month screen . Unstable angina within 14 day screen , evidence myocardial ischemia . Moderate severe pulmonary hypertension . Valvular stenosis , hypertrophic , restrictive obstructive cardiomyopathy , constrictive pericarditis , primary pulmonary hypertension , biopsy proven active myocarditis . Sustained VT Vfib within 14 day screen . Sustained Atrial Fibrillation . Second third degree AV block without permanent cardiac pacemaker . CVA within 3 month screen , evidence significantly compromise CNS perfusion . Total bilirubin &gt; 1.5 mg/dL AST ALT 1.5 time upper limit normal range . Renal insufficiency assess calculated GFR &lt; 60 ml/min ( CockroftGault equation ) . Serum sodium &lt; 125 mEq/dL &gt; 160 mEq/dL . Serum potassium &lt; 3.5 mEq/dL &gt; 5.0 mEq/dL . Women take hormonal contraceptive . Body Mass Index ( BMI ) &gt; 35 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>hypertension treatment</keyword>
</DOC>